Boothe Investment Group’s AbbVie ABBV Stock Holding History

Boothe Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.98M	Buy	31,708 +877	+3%	+$189K	2.51%	14
2026 Q1	$6.71M	Buy	30,831 +498	+2%	+$110K	2.16%	18
2025 Q4	$6.93M	Buy	30,333 +870	+3%	+$198K	2.48%	14
2025 Q3	$6.82M	Buy	29,463 +264	+0.9%	+$53.8K	2.5%	15
2025 Q2	$5.42M	Buy	+29,199	New	+$5.43M	2.07%	20
2022 Q1	–	Sell	-66,483	Closed	-$9M	–	33
2021 Q4	$9M	Buy	66,483 +266	+0.4%	+$31.4K	4.81%	6
2021 Q3	$7.22M	Buy	66,217 +1,849	+3%	+$211K	3.94%	9
2021 Q2	$7.36M	Buy	64,368 +2,769	+4%	+$312K	3.86%	11
2021 Q1	$6.67M	Buy	61,599 +19,911	+48%	+$2.13M	3.89%	10
2020 Q4	$4.47M	Buy	41,688 +2,092	+5%	+$201K	3.08%	16
2020 Q3	$3.47M	Buy	39,596 +275	+0.7%	+$25.9K	2.96%	16
2020 Q2	$3.86M	Buy	+39,321	New	+$3.46M	3.42%	11

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boothe Investment Group's ABBV Position: Q2 2026 in Review

Boothe Investment Group increased its AbbVie (ABBV) stake by 2.8% in Q2 2026, buying an estimated $189K and bringing the position to 31,708 shares worth $7.98M. The position accounts for 2.51% of the portfolio, ranked #14.

Boothe Investment Group first reported a position in ABBV in Q2 2020 and has held it in 12 quarters since. The position peaked at $9M in Q4 2021. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Boothe Investment Group held 31,708 shares of AbbVie worth $7.98M as of Q2 2026.
Boothe Investment Group bought 877 AbbVie shares in Q2 2026, an estimated $189K.
AbbVie made up 2.51% of Boothe Investment Group's portfolio in Q2 2026, its #14 holding.
Boothe Investment Group first reported a position in AbbVie in Q2 2020 and has held it in 12 quarters since.
Boothe Investment Group's AbbVie position peaked at $9M in Q4 2021.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Boothe Investment Group's 13F filing for Q2 2026, filed 14 Jul 2026.